NCT07177417View on ClinicalTrials.gov

Characterizing the Human Airway Immune Response to FluMist Vaccination

PHASE4RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 9, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

November 30, 2028

Conditions
Healthy Young AdultsInfluenza VaccinesInfluenza Vaccine Response
Interventions
BIOLOGICAL

FluMist

intranasal administered live attenuated influenza vaccine

BIOLOGICAL

inactivated influenza vaccine

intramuscular administered inactivated influenza vaccine

PROCEDURE

bronchoscopy

bronchoscopy with bronchoalveolar lavage and endobronchial biopsy sampling

Trial Locations (1)

63110

RECRUITING

Washington University in Saint Louis School of Medicine Emergency Care and Research Core, St Louis

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Washington University School of Medicine

OTHER